biotech news

BERKELEY, Californie et MAINZ, Allemagne et NEW YORK, 19 ao?t 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ : MYNZ) (<> ou la <>), une soci?t? de diagnostic en g?n?tique mol?culaire … [Read more...] about Mainz Biomed et Dante Genomics annoncent la disponibilit? commerciale totale de ColoAlert en Italie et aux ?mirats arabes unis

BERKELEY, Kalifornien, USA, MAINZ, Deutschland, und NEW YORK, USA, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (,,Mainz Biomed" oder das ,,Unternehmen"), ein Unternehmen im … [Read more...] about Mainz Biomed und Dante Genomics geben volle kommerzielle Verf?gbarkeit von ColoAlert in Italien und den Vereinigten Arabischen Emiraten bekannt

BERKELEY, California, MAINZ, Germania e NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz'' o "l'Azienda"), un'azienda di diagnostica molecolare genetica … [Read more...] about Mainz Biomed e Dante Genomics annunciano la disponibilit? commerciale di ColoAlert in Italia e negli Emirati Arabi Uniti

BERKELEY, California y MAINZ, Alemania y NUEVA YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz'" o la "Compa??a"), una firma de diagn?stico de gen?tica molecular que … [Read more...] about Mainz Biomed y Dante Genomics anuncian la disponibilidad comercial total de ColoAlert en Italia y los Emiratos ?rabes Unidos

BERKELEY, Californi? en MAINZ, Duitsland en NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ('Mainz' of het 'bedrijf'), een diagnostisch bedrijf op het gebied van … [Read more...] about Mainz Biomed en Dante Genomics kondigen volledige commerci?le beschikbaarheid van ColoAlert aan in Itali? en de Verenigde Arabische Emiraten

FDA granted Priority Review designationPDUFA target action date is February 17, 2023FDA stated that it is not currently planning to hold an advisory committee meeting PITTSBURGH, Aug. 18, 2022 … [Read more...] about FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa

WINNIPEG, Manitoba, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company" or "Kane Biotech"), a biotechnology company engaged in the research, development and … [Read more...] about Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 – Conference Call to Follow

AMITYVILLE, N,Y., Aug. 18, 2022 (GLOBE NEWSWIRE) -- The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and … [Read more...] about The Greenrose Holding Company to Hold Rescheduled Second Quarter 2022 Conference Call on August 22, 2022 at 5:00 p.m. ET

LEXINGTON, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced … [Read more...] about T2 Biosystems to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

MALVERN, Pa., Aug. 18, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that … [Read more...] about TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares